Back
Exelixis Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
54
EXEL
Exelixis
Last Price:
22.11
Seasonality Move:
6.45%
Buy
62
REGN
Regeneron Pharmaceuticals
Last Price:
937.69
Seasonality Move:
11.17%
Buy
54
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $21.92. The Score for EXEL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $903.02. The Score for REGN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $903.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 36.55 | Sell |
| Chaikin Money Flow: | 4060293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.72 - 23.74) | Sell |
| Bollinger Bands (100): | (21.58 - 23.66) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -14.77 | Sell |
| Relative Strength Index (14 RSI): | 42.79 | Sell |
| Chaikin Money Flow: | 84431 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (892.3 - 946.4) | Sell |
| Bollinger Bands (100): | (887.77 - 967.91) | Sell |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.28 | Sell |
| 20-day SMA: | 23.12 | Sell |
| 50-day SMA: | 22.88 | Sell |
| 200-day SMA: | 21.92 | Sell |
| 8-day EMA: | 23.08 | Sell |
| 20-day EMA: | 23.12 | Sell |
| 50-day EMA: | 22.89 | Sell |
| 200-day EMA: | 21.79 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 896.7 | Buy |
| 20-day SMA: | 909 | Sell |
| 50-day SMA: | 944.59 | Sell |
| 200-day SMA: | 866.6 | Buy |
| 8-day EMA: | 897.18 | Buy |
| 20-day EMA: | 909.84 | Sell |
| 50-day EMA: | 925.72 | Sell |
| 200-day EMA: | 876.52 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.03 per share, an increase this year of $0.54 per share, and an increase next year of $0.32 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.26 per share, an increase next quarter of $0.00 per share, an increase this year of $2.66 per share, and an increase next year of $2.13 per share.
Exelixis Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||